State Stem Cell Agency ICOC Strategic Planning Advisory Committee Agenda 6/13/06

Jun 13, 2006
Main Location: 

California Institute for Regenerative Medicine
210 King Street, 3rd Floor
San Francisco, CA 94107

 

 

 

California State Stem Cell Agency

Regular Meeting : Strategic Planning Advisory Committee

SCIENTIFIC & MEDICAL RESEARCH FUNDING WORKING GROUP
(GRANTS REVIEW WORKING GROUP)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

 

OPEN SESSION

  1. Welcome
  2. Progress Report
      a. Interviews
      b. Meetings
           i. Update on July 13th Scientific Conference for the ICOC and the Public
           ii. Report on June 1,2 ICOC Meeting
  3. Discussion Topics
    1. Cord Blood: CIRM’s Role?   Discussion Leader:  Dr. Zach Hall
    2. Databank for hESC lines?   Discussion Leader: Dr. Zach Hall         
  4. Public Comment

    [Members of the Public will be invited to provide testimony before or during consideration of each agenda item. Speakers are asked to limit their testimony to three (3) minutes.]

  5. Adjournment

 

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

 


 

**NOTICE**

 

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at http://www.cirm.ca.gov.

 

© 2013 California Institute for Regenerative Medicine